Glucagon-like peptide-1
US$ 29.70
glp 1 wikipedia File:Principals funcions GLP-1.png Glucagon-like peptide-1 receptor - Wikipedia
Description
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease
Manufacturers like Eli Lilly and Novo Nordisk plan to manufacture and distribute GLP-1 drugs in the future
The detailed background of the (patho)physiology of the incretin system and the history of the development of incretin-based glucose-lowering medications have recently been reviewed [15,16]
"Novo Nordisk says stopping obesity drug may cause full weight regain in 5 years"
